NCT03446937 2018.

Study name	Effect of antenatal corticosteroids on neonatal morbidity
Methods	Randomised parallel assignment three‐arm trial Blinding: participant, care provider, investigator Setting: Ahmadu Bello University Teaching Hospital Shika‐Zaria, Nigeria
Participants	100 participants Inclusion criteria Pregnant women at 34 weeks 0 days to 36 weeks 6 days of gestation and a probability of delivery in the late preterm period irrespective of diagnosis who give consent. Pregnant women at 34 weeks 0 days to 36 weeks 6 days of gestation scheduled for elective/emergency delivery in the late preterm period irrespective of indication and route of delivery who give consent. Exclusion criteria Evidence of chorioamnionitis Evidence of fetal distress History of use of antenatal corticosteroids in index pregnancy Women who do not give consent
Interventions	Group 1: dexamethasone sodium phosphate injection 12 mg X doses to be given 12 hours apart Group 2: betamethasone sodium phosphate injection12 mg X 2 doses given 12 hours apart Group 3: placebo. two doses of intramuscular injection of water for injection given 12 hours apart
Outcomes	Primary outcomes Neonatal Respiratory distress syndrome (Time Frame: within the first 72 hours of life) Tachypnoea with grunting, recession, or nasal flaring with diffuse reticulogranular infiltrate on X‐ray and oxygen requirement. Secondary outcomes Transient tachypnoea of the newborn within the first 72 hours after delivery/birth Admission into neonatal intensive care unit within the first 72 hours after delivery/birth Admission into neonatal intensive care unit. Apnoea. Within the first 72 hours after delivery/birth ]
Starting date	Start date: December 2017 Completion date: May 2019
Contact information	Anisah Yahya, MBBS, Ahmadu Bello University, Nigeria moc.oohay@yhasina
Notes

ACS: antenatal corticosteroids
NICU: neonatal intensive care unit